eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Otsuka and Bristol-Myers Squibb

Hunton House, Highbridge Estate, Oxford Road, Uxbridge, Middlesex, UB8 1DH, UK
Telephone: +44(0)1895 207100 (Otsuka)
Telephone: +44(0)1895 523000 (BMS)
Fax: +44 (0)1895 523010 (BMS)
Fax: +44(0)1895 523677 BMS
Fax: +44 (0)1895 207115 (Otsuka)
Medical Information Direct Line: +44(0)800 731 1736 BMS
Medical Information e-mail: medical.information@bms.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?


Patient Information Leaflet last updated on the eMC: 07/10/2011
PIL Abilify 7.5 mg/ml solution for injection (intramuscular) (Otsuka & Bristol-Myers Squibb)

The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. This PIL is in PDF format.

View Patient Information Leaflet (0.121MB)

Are you having problems reading or printing this PDF? Visit adobe.com and download the Adobe Acrobat Reader.


More information about this product

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/20801/PIL/


Black Triangle

This medicine is monitored intensively by the CHM and MHRA

Active Ingredients/Generics

 
   aripiprazole